We are analyzing https://link.springer.com/article/10.1186/1475-2867-3-5.

Title:
NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells | Cancer Cell International
Description:
Changes of membrane lipids in cisplatin-sensitive A549 and cisplatin-resistant A549/DDP cells during the apoptotic process induced by a clinical dose of cisplatin (30 μM) were detected by 1H and 31P-NMR spectroscopy and by membrane fluidity measurement. The apoptotic phenotypes of the two cell lines were monitored with flow cytometry. The assays of apoptosis showed that significant apoptotic characteristics of the A549 cells were induced when the cells were cultured for 24 hours after treatment with cisplatin, while no apoptotic characteristic could be detected for the resistant A549/DDP cells even after 48 hours. The results of 1H-NMR spectroscopy demonstrated that the CH2/CH3 and Glu/Ct ratios of the membrane of A549 cells increased significantly, but those in A549/DDP cell membranes decreased. In addition, the Chol/CH3 and Eth/Ct ratios decreased for the former but increased for the latter cells under the same conditions. 31P-NMR spectroscopy indicated levels of phosphomonoesters (PME) and ATP decreased in A549 but increased in A549/DDP cells after being treated with cisplatin. These results were supported with the data obtained from 1H-NMR measurements. The results clearly indicated that components and properties of membrane phospholipids of the two cell lines were significantly different during the apoptotic process when they were treated with a clinical dose of cisplatin. Plasma membrane fluidity changes during cisplatin treatment as detected with the fluorescence probe TMA-DPH also indicate marked difference between the two cell lines. We provided evidence that there are significant differences in plasma membrane changes during treatment of cisplatin sensitive A549 and resistant A549/DDP cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cells, membrane, cell, addp, cisplatin, google, scholar, article, plasma, cas, cancer, resistant, pubmed, lines, hnmr, sensitive, human, apoptotic, pnmr, resistance, apoptosis, nmr, lipids, ratios, treated, fig, microviscosity, authors, data, spectra, peak, ppm, spectroscopy, drug, tumor, induced, increased, phospholipids, tmadph, content, research, huang, clinical, dose, pme, fluorescence, increase, figure, table, resonance,

Topics {✒️}

cisplatin-resistant a549/ddp cells human ovarian-carcinoma cells 2-dimethyl-2-silapentane-5-sulfonic acid open access license 1d 1h-nmr spectra cytidine triphosphate cytidylyl-transferase cell line a549/ddp jinfeng wang & youguo huang single-quantum nmr-spectroscopy 1h-nmr spectroscopy demonstrated resistant a549/ddp cells resistant cells a549/ddp a549/ddp cells responding author information authors resistant a549/ddp treated article download pdf lung resistant protein full size image yufeng tong carried a549/ddp cells treated a549/ddp cells [fig fluorescence probe tma-dph a549/ddp cells obtained cationic derivative tma-dph anti-cancer drug cisplatin 31p-nmr spectroscopy 31p-nmr spectra 1h-nmr spectroscopy 1h-nmr spectroscopy [18 full size table multi-drug resistance protein 1h-nmr spectra 1h-nmr samples cultured 31p-nmr studies 31p-nmr measurements yufeng tong 1h-nmr measurements privacy choices/manage cookies resistant a549/ddp full access molecular mechanism involved human leukemic lymphoblast resistant 549/ddp cells saturated fatty acid renal cell carcinoma authors’ original file lipid signal modification 31p-nmr experiments plasma membrane lipids neuronal cell line

Schema {🗺️}

WebPage:
      mainEntity:
         headline:NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells
         description:Changes of membrane lipids in cisplatin-sensitive A549 and cisplatin-resistant A549/DDP cells during the apoptotic process induced by a clinical dose of cisplatin (30 μM) were detected by 1H and 31P-NMR spectroscopy and by membrane fluidity measurement. The apoptotic phenotypes of the two cell lines were monitored with flow cytometry. The assays of apoptosis showed that significant apoptotic characteristics of the A549 cells were induced when the cells were cultured for 24 hours after treatment with cisplatin, while no apoptotic characteristic could be detected for the resistant A549/DDP cells even after 48 hours. The results of 1H-NMR spectroscopy demonstrated that the CH2/CH3 and Glu/Ct ratios of the membrane of A549 cells increased significantly, but those in A549/DDP cell membranes decreased. In addition, the Chol/CH3 and Eth/Ct ratios decreased for the former but increased for the latter cells under the same conditions. 31P-NMR spectroscopy indicated levels of phosphomonoesters (PME) and ATP decreased in A549 but increased in A549/DDP cells after being treated with cisplatin. These results were supported with the data obtained from 1H-NMR measurements. The results clearly indicated that components and properties of membrane phospholipids of the two cell lines were significantly different during the apoptotic process when they were treated with a clinical dose of cisplatin. Plasma membrane fluidity changes during cisplatin treatment as detected with the fluorescence probe TMA-DPH also indicate marked difference between the two cell lines. We provided evidence that there are significant differences in plasma membrane changes during treatment of cisplatin sensitive A549 and resistant A549/DDP cells.
         datePublished:2003-04-08T00:00:00Z
         dateModified:2003-04-08T00:00:00Z
         pageStart:1
         pageEnd:8
         sameAs:https://doi.org/10.1186/1475-2867-3-5
         keywords:
            A549 cells
            cisplatin
            membrane lipids
             1H-NMR
             31P-NMR
            Cancer Research
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig4_HTML.jpg
         isPartOf:
            name:Cancer Cell International
            issn:
               1475-2867
            volumeNumber:3
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhenhua Huang
               affiliation:
                     name:Chinese Academy of Sciences
                     address:
                        name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yufeng Tong
               affiliation:
                     name:Chinese Academy of Sciences
                     address:
                        name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jinfeng Wang
               affiliation:
                     name:Chinese Academy of Sciences
                     address:
                        name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Youguo Huang
               affiliation:
                     name:Chinese Academy of Sciences
                     address:
                        name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cells
      description:Changes of membrane lipids in cisplatin-sensitive A549 and cisplatin-resistant A549/DDP cells during the apoptotic process induced by a clinical dose of cisplatin (30 μM) were detected by 1H and 31P-NMR spectroscopy and by membrane fluidity measurement. The apoptotic phenotypes of the two cell lines were monitored with flow cytometry. The assays of apoptosis showed that significant apoptotic characteristics of the A549 cells were induced when the cells were cultured for 24 hours after treatment with cisplatin, while no apoptotic characteristic could be detected for the resistant A549/DDP cells even after 48 hours. The results of 1H-NMR spectroscopy demonstrated that the CH2/CH3 and Glu/Ct ratios of the membrane of A549 cells increased significantly, but those in A549/DDP cell membranes decreased. In addition, the Chol/CH3 and Eth/Ct ratios decreased for the former but increased for the latter cells under the same conditions. 31P-NMR spectroscopy indicated levels of phosphomonoesters (PME) and ATP decreased in A549 but increased in A549/DDP cells after being treated with cisplatin. These results were supported with the data obtained from 1H-NMR measurements. The results clearly indicated that components and properties of membrane phospholipids of the two cell lines were significantly different during the apoptotic process when they were treated with a clinical dose of cisplatin. Plasma membrane fluidity changes during cisplatin treatment as detected with the fluorescence probe TMA-DPH also indicate marked difference between the two cell lines. We provided evidence that there are significant differences in plasma membrane changes during treatment of cisplatin sensitive A549 and resistant A549/DDP cells.
      datePublished:2003-04-08T00:00:00Z
      dateModified:2003-04-08T00:00:00Z
      pageStart:1
      pageEnd:8
      sameAs:https://doi.org/10.1186/1475-2867-3-5
      keywords:
         A549 cells
         cisplatin
         membrane lipids
          1H-NMR
          31P-NMR
         Cancer Research
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1475-2867-3-5/MediaObjects/12935_2002_Article_24_Fig4_HTML.jpg
      isPartOf:
         name:Cancer Cell International
         issn:
            1475-2867
         volumeNumber:3
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhenhua Huang
            affiliation:
                  name:Chinese Academy of Sciences
                  address:
                     name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yufeng Tong
            affiliation:
                  name:Chinese Academy of Sciences
                  address:
                     name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jinfeng Wang
            affiliation:
                  name:Chinese Academy of Sciences
                  address:
                     name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Youguo Huang
            affiliation:
                  name:Chinese Academy of Sciences
                  address:
                     name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Cell International
      issn:
         1475-2867
      volumeNumber:3
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Chinese Academy of Sciences
      address:
         name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Sciences
      address:
         name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Sciences
      address:
         name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
         type:PostalAddress
      name:Chinese Academy of Sciences
      address:
         name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhenhua Huang
      affiliation:
            name:Chinese Academy of Sciences
            address:
               name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
               type:PostalAddress
            type:Organization
      name:Yufeng Tong
      affiliation:
            name:Chinese Academy of Sciences
            address:
               name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
               type:PostalAddress
            type:Organization
      name:Jinfeng Wang
      affiliation:
            name:Chinese Academy of Sciences
            address:
               name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Youguo Huang
      affiliation:
            name:Chinese Academy of Sciences
            address:
               name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
      name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
      name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
      name:National Laboratory of Biomacromolecules, Center for Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

External Links {🔗}(113)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.51s.

LINK . SPRINGER . COM {}